Business
Add as a preferred source on GoogleThe company linked the outlook to nine-month performance and expected fourth-quarter pressure from TDAPA regulations and inflation.
Fresenius Medical Care's third-quarter release put its 2026 operating income growth forecast between no change and a mid-single-digit decline, on a constant-currency basis and excluding special items.
The company tied the outlook to nine-month operating-income performance and fourth-quarter pressure expected from TDAPA regulations and inflation.
Third-quarter revenue rose to CHF 667.1 million. Nine-month organic growth was 8.3%.
Third-quarter bookings climbed 16% year over year, and Dover raised its organic-growth floor to 5%.
Net income rose 31.2% to $920 million, while specialty rental revenue increased 34.7%.
